894 related articles for article (PubMed ID: 16489840)
21. Viral diseases of the skin: diagnosis and antiviral treatment.
Trizna Z
Paediatr Drugs; 2002; 4(1):9-19. PubMed ID: 11817982
[TBL] [Abstract][Full Text] [Related]
22. [Clinical picture of Herpesviridae infections among immunocompromised patients: bone marrow and solid organ transplants recipients].
Simon K; Dziemianko I
Przegl Epidemiol; 2003; 57(2):289-97. PubMed ID: 12910597
[TBL] [Abstract][Full Text] [Related]
23. Antiviral therapy of herpes simplex and varicella-zoster virus infections.
Wutzler P
Intervirology; 1997; 40(5-6):343-56. PubMed ID: 9675639
[TBL] [Abstract][Full Text] [Related]
24. Topical and intralesional cidofovir: a review of pharmacology and therapeutic effects.
Zabawski EJ; Cockerell CJ
J Am Acad Dermatol; 1998 Nov; 39(5 Pt 1):741-5. PubMed ID: 9810890
[TBL] [Abstract][Full Text] [Related]
25. Advances in antiviral therapy.
Wu JJ; Pang KR; Huang DB; Tyring SK
Dermatol Clin; 2005 Apr; 23(2):313-22. PubMed ID: 15837157
[TBL] [Abstract][Full Text] [Related]
26. Valaciclovir. A review of its antiviral activity, pharmacokinetic properties and therapeutic efficacy in herpesvirus infections.
Perry CM; Faulds D
Drugs; 1996 Nov; 52(5):754-72. PubMed ID: 9118821
[TBL] [Abstract][Full Text] [Related]
27. Infection due to acyclovir resistant herpes simplex virus in patients undergoing allogeneic hematopoietic stem cell transplantation.
Venard V; Dauendorffer JN; Carret AS; Corsaro D; Edert D; Bordigoni P; Le Faou A
Pathol Biol (Paris); 2001 Sep; 49(7):553-8. PubMed ID: 11642018
[TBL] [Abstract][Full Text] [Related]
28. Herpesvirus infections in solid organ transplant patients at high risk of primary cytomegalovirus disease.
Razonable RR; Brown RA; Humar A; Covington E; Alecock E; Paya CV;
J Infect Dis; 2005 Oct; 192(8):1331-9. PubMed ID: 16170749
[TBL] [Abstract][Full Text] [Related]
29. Brincidofovir (CMX-001) for refractory and resistant CMV and HSV infections in immunocompromised cancer patients: A single-center experience.
El-Haddad D; El Chaer F; Vanichanan J; Shah DP; Ariza-Heredia EJ; Mulanovich VE; Gulbis AM; Shpall EJ; Chemaly RF
Antiviral Res; 2016 Oct; 134():58-62. PubMed ID: 27582067
[TBL] [Abstract][Full Text] [Related]
30. Varicella-zoster infection after allogeneic bone marrow transplantation: incidence, risk factors and prevention with low-dose aciclovir and ganciclovir.
Steer CB; Szer J; Sasadeusz J; Matthews JP; Beresford JA; Grigg A
Bone Marrow Transplant; 2000 Mar; 25(6):657-64. PubMed ID: 10734301
[TBL] [Abstract][Full Text] [Related]
31. Antiviral drug resistance in herpesviruses other than cytomegalovirus.
Piret J; Boivin G
Rev Med Virol; 2014 May; 24(3):186-218. PubMed ID: 24604770
[TBL] [Abstract][Full Text] [Related]
32. Management of acyclovir-resistant herpes simplex and varicella-zoster virus infections.
Balfour HH; Benson C; Braun J; Cassens B; Erice A; Friedman-Kien A; Klein T; Polsky B; Safrin S
J Acquir Immune Defic Syndr (1988); 1994 Mar; 7(3):254-60. PubMed ID: 8106965
[TBL] [Abstract][Full Text] [Related]
33. Orofacial viral infections in the immunocompromised host.
Samonis G; Mantadakis E; Maraki S
Oncol Rep; 2000; 7(6):1389-94. PubMed ID: 11032950
[TBL] [Abstract][Full Text] [Related]
34. Drugs for non-HIV viral infections.
Med Lett Drugs Ther; 2002 Feb; 44(1123):9-16. PubMed ID: 11828264
[No Abstract] [Full Text] [Related]
35. Aciclovir. A reappraisal of its antiviral activity, pharmacokinetic properties and therapeutic efficacy.
Wagstaff AJ; Faulds D; Goa KL
Drugs; 1994 Jan; 47(1):153-205. PubMed ID: 7510619
[TBL] [Abstract][Full Text] [Related]
36. Management of herpes simplex and varicella-zoster virus infections.
Erlich KS
West J Med; 1997 Mar; 166(3):211-5. PubMed ID: 9143202
[TBL] [Abstract][Full Text] [Related]
37. Recent developments in anti-herpesvirus drugs.
Field HJ; Vere Hodge RA
Br Med Bull; 2013; 106():213-49. PubMed ID: 23596085
[TBL] [Abstract][Full Text] [Related]
38. New antiherpesvirus agents. Their targets and therapeutic potential.
Alrabiah FA; Sacks SL
Drugs; 1996 Jul; 52(1):17-32. PubMed ID: 8799682
[TBL] [Abstract][Full Text] [Related]
39. Immunocompromised hosts: perspectives in the treatment and prophylaxis of cytomegalovirus disease in solid-organ transplant recipients.
Torres-Madriz G; Boucher HW
Clin Infect Dis; 2008 Sep; 47(5):702-11. PubMed ID: 18652557
[TBL] [Abstract][Full Text] [Related]
40. Topical cidofovir for severe cutaneous human papillomavirus and molluscum contagiosum infections in patients with HIV/AIDS. A pilot study.
Calista D
J Eur Acad Dermatol Venereol; 2000 Nov; 14(6):484-8. PubMed ID: 11444271
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
